Millipore Corporation To Present At Merrill Lynch Investor Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 7, 2006--Millipore Corporation (NYSE:MIL), a leading provider of products and services that improve productivity in the laboratory and in biopharmaceutical manufacturing, today announced that its President, Chairman & CEO, Martin Madaus, will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Thursday, February 9, 2006 at 11:00 a.m. ET at the Grand Hyatt Hotel in New York. The webcast will be open to interested parties by accessing Millipore’s website at www.millipore.com.

MORE ON THIS TOPIC